SCHEMBL16321708

SCHEMBL16321708

O=[N+]([O-])c1ccccc1-c1cccc2c1ccn2-c1cccc(-c2cccnc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ LMNA P02545 1/20 0.42
▸ USP1 O94782 1/20 0.42
▸ WDR48 Q8TAF3 1/20 0.42
▸ MAPK1 P28482 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ MAPT P10636 3/20 0.38
▸ RAB9A P51151 3/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ CCR6 P51684 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP2A6 P11509 2/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ EGFR P00533 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16340993 0.79 EIF4E (0.41) LMNAMAPTTDP1HTTALDH1A1
SCHEMBL15568528 0.72 TDP1 (0.46) MAPK1MAPTTDP1MEN1KMT2A
SCHEMBL20426870 0.72 CYP2A6 (0.38) MAPTCYP2A6DHPSMAPK14
SCHEMBL6845658 0.72 VHL (0.47) MAPTPOLBCYP2A6DHPSMAPK14
SCHEMBL3237419 0.72 ALDH1A1 (0.65) L3MBTL1NPC1LMNAUSP1WDR48
SCHEMBL30058255 0.72 ALDH1A1 (0.65) L3MBTL1NPC1LMNAUSP1WDR48
SCHEMBL16948245 0.71 MAPT (0.38) MAPTPOLBALDH1A1CYP2A6ABL1
SCHEMBL20426957 0.71 MAPT (0.36) NPC1MAPTRAB9AALDH1A1CYP2A6
SCHEMBL16341534 0.70 CDK4 (0.44) NPC1KDM4EMAPTRAB9AMEN1
SCHEMBL20427219 0.70 CYP2A6 (0.42) NPC1MAPTRAB9ATDP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-20140374724-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2014-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU L3MBTL1 464/4885NPC1 2684/4885LMNA 2814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback